Scarica l'app Stockscreener
4.165
22.83%
-1.245
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SGHT Giù?
Forum
Previsione
Precedente Chiudi:
$5.41
Aprire:
$4.8
Volume 24 ore:
846.60K
Relative Volume:
3.02
Capitalizzazione di mercato:
$220.21M
Reddito:
$81.06M
Utile/perdita netta:
$-55.55M
Rapporto P/E:
-3.6535
EPS:
-1.14
Flusso di cassa netto:
$-47.98M
1 W Prestazione:
-21.52%
1M Prestazione:
-26.63%
6M Prestazione:
+13.14%
1 anno Prestazione:
+72.52%
Intervallo 1D:
$3.81
$4.8674
Intervallo di 1 settimana:
$3.81
$5.66
Portata 52W:
$2.03
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Nome
Sight Sciences Inc
Settore
Industria
Telefono
(415) 889-0550
Indirizzo
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
4.165 | 286.04M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
111.04 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
371.40 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
92.74 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.32 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.74 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | Aggiornamento | Lake Street | Hold → Buy |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-11-04 | Downgrade | Lake Street | Buy → Hold |
| 2024-08-21 | Iniziato | Lake Street | Buy |
| 2023-09-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-09-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | Downgrade | Citigroup | Buy → Neutral |
| 2023-01-06 | Aggiornamento | Stifel | Hold → Buy |
| 2022-10-04 | Iniziato | Needham | Hold |
| 2022-07-26 | Iniziato | Stifel | Hold |
| 2022-02-03 | Iniziato | William Blair | Outperform |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Sight Sciences Inc Borsa (SGHT) Ultime notizie
William Blair reiterates Sight Sciences stock rating on expense control - Investing.com
Sight Sciences Q4 Net Loss Narrows; Expects 6-14% Revenue Growth In FY26 - Nasdaq
Sight Sciences sees FY26 revenue $82M-$88M, consensus $86.11M - TipRanks
Sight Sciences Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises - Investing.com Nigeria
Sight Sciences Q4 Earnings Call Highlights - MarketBeat
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates - Bitget
Sight Sciences (SGHT) Q4 2025 Earnings Transcript - AOL.com
Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Sight Sciences reports Q4 EPS (8c), consensus (14c) - TipRanks
Sight Sciences Q4 Loss Narrows, Revenue Rises - marketscreener.com
Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Sight Sciences (NASDAQ:SGHT) Issues Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
Sight Sciences Q4 Earnings Assessment - Benzinga
Sight Sciences Posts Q4 Growth, Issues 2026 Outlook - TipRanks
SGHT: OMNI and TearCare drive innovation in eyecare, targeting large, underserved markets - TradingView
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance - The Manila Times
Sight Sciences (SGHT) outlines interventional glaucoma and dry eye growth plan - Stock Titan
Sight Sciences (NASDAQ: SGHT) narrows 2025 loss and targets 6–14% growth - Stock Titan
SGHT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Uncovering Potential: Sight Sciences's Earnings Preview - Benzinga
5 Analysts Assess Sight Sciences: What You Need To Know - Benzinga
Stifel Nicolaus Issues Positive Forecast for Sight Sciences (NASDAQ:SGHT) Stock Price - MarketBeat
Stifel raises Sight Sciences stock price target on TearCare survey - Investing.com
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SGHT SEC FilingsSight Sciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Sight Sciences (NASDAQ:SGHT) Has Debt But No Earnings; Should You Worry? - 富途牛牛
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Finviz
Sight Sciences, Inc. (SGHT) Projected to Surpass Earnings Predictions: Will the Share Price Rise? - Bitget
Sight Sciences (SGHT) Projected to Post Quarterly Earnings on Wednesday - Defense World
[Form 4] Sight Sciences, Inc. Insider Trading Activity - Stock Titan
Should you avoid Sight Sciences Inc. stock right nowJuly 2025 Rallies & Precise Buy Zone Identification - mfd.ru
Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - The Manila Times
Sight Sciences, Inc. Scheduled to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - Quiver Quantitative
Will Sight Sciences Inc. stock rally after Fed decisionsJuly 2025 PostEarnings & Intraday High Probability Setup Alerts - mfd.ru
Why Sight Sciences Inc. stock is recommended by analystsWeekly Stock Summary & Accurate Trade Setup Notifications - mfd.ru
Will Sight Sciences Inc. stock recover after earningsQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - mfd.ru
Can Sight Sciences Inc. be recession proof2025 Trade Ideas & Fast Entry Momentum Alerts - mfd.ru
KCK LTD. Adjusts Holdings in Sight Sciences Inc: A Strategic Por - GuruFocus
Chart Watch: Will Sight Sciences Inc outperform tech stocks2025 Top Decliners & Stepwise Swing Trade Plans - baoquankhu1.vn
Sight Sciences: Investor Attention Shifts to 2026 Milestones - AD HOC NEWS
Aug Action: Is Sight Sciences Inc on track to beat earningsBear Alert & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Market Catalysts: Is Sight Sciences Inc subject to activist investor interest2025 Pullback Review & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Sight Sciences Extends Menlo Park Headquarters Lease Agreement - The Globe and Mail
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Sight Sciences extends Menlo Park headquarters lease with rent abatement period By Investing.com - Investing.com India
Sight Sciences extends Menlo Park headquarters lease with rent abatement period - Investing.com Canada
Sight Sciences (NASDAQ:SGHT) Raised to “Strong-Buy” at William Blair - Defense World
Sight Sciences (NASDAQ:SGHT) Raised to Strong-Buy at William Blair - MarketBeat
William Blair resumes Sight Sciences stock with Outperform rating By Investing.com - Investing.com Australia
William Blair resumes Sight Sciences stock with Outperform rating - Investing.com
Sight Sciences Inc Azioni (SGHT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):